The beforehand wholesome teenager mentioned he believes the vaccine precipitated him to develop the uncommon neurological dysfunction, however medical doctors mentioned it might simply be a coincidence.
A Texas teenager recognized with Guillain-Barré syndrome (GBS) just a few weeks after his first dose of the COVID-19 vaccine mentioned he believes the vaccine is in charge, in line with a native Houston information channel KPRC2 report. “I wished to get the vaccine,” mentioned Wyatt McGlaun, a highschool senior from The Woodlands. “I felt it was the fitting factor to do. I wished to journey and revel in my final summer time earlier than faculty.”
Just a few weeks after receiving the vaccine, McGlaun grew to become weak and had problem strolling. He was admitted to CHI St. Luke’s Well being the place he was recognized with GBS.
Information studies didn’t disclose which COVID vaccine McGlaun obtained. In keeping with Mayo Clinic, GBS is a uncommon dysfunction by which the physique’s immune system assaults its nerves. Preliminary signs embody weak point and tingling within the extremities which may rapidly unfold, finally paralyzing the entire physique. Most individuals with the situation should be hospitalized to obtain therapy.
Individuals with GBS normally expertise their most vital weak point inside two weeks after signs start. In keeping with the Nationwide Institute of Well being, one case of GBS was reported in February in an 82-year-old lady who had one dose of Pfizer’s COVID vaccine.
In keeping with information from the Vaccine Adversarial Occasions Reporting System (VAERS), there have been 70 reported instances of GBS after having obtained a COVID vaccine with 59% occurring with Pfizer, 44% with Moderna and three% with Johnson & Johnson (J&J).